For decades, Hyaluronic Acid (HA) has been the undisputed protagonist of skin quality treatments. However, a new class of biological molecules is redefining the landscape of tissue repair: Polynucleotides (PN). While HA provides immediate volume and hydration by binding water, Polynucleotides work at the cellular level to “prime” and regenerate the skin’s biological environment.
Polynucleotides are natural DNA fractions that act as biostimulators, signaling cells to accelerate their natural repair mechanisms. In an era where patients seek “bio-harmonization,” PN therapy is becoming a fundamental prerequisite for any advanced aesthetic plan.
1. Mechanism of Action: The Trophic Effect
Polynucleotides function through a multi-faceted biological approach that differs significantly from traditional fillers:
-
Fibroblast Stimulation: PN molecules bind to cell receptors, triggering the proliferation of fibroblasts and increasing the production of Type I collagen and elastin.
-
Ischemic Tissue Repair: They promote angiogenesis (the formation of new blood vessels), improving microcirculation and nutrient delivery to the skin.
-
Antioxidant Activity: PN acts as a free-radical scavenger, protecting the skin from oxidative stress and UV damage.
-
Deep Hydration: Through their degraded metabolites, they enhance the skin’s internal ability to retain moisture without the “heaviness” of cross-linked HA.
2. PN vs. HA: Distinguishing the Clinical Utility
It is crucial for practitioners to understand that Polynucleotides are not “replacements” for Hyaluronic Acid, but rather synergistic partners.
| Feature | Hyaluronic Acid (HA) | Polynucleotides (PN) |
| Primary Function | Physical hydration and volumization | Cellular regeneration and repair |
| Target | Extracellular matrix | Fibroblast activity and DNA repair |
| Result | Immediate plumping | Gradual improvement in texture and elasticity |
| Best For | Volume loss and deep wrinkles | Skin laxity, scarring, and dark circles |
3. Strategic Clinical Applications
Polynucleotides excel in delicate areas where traditional fillers might carry higher risks of edema or visibility.
-
The Periocular Area: PN is the gold standard for treating the “tear trough” and crepey skin around the eyes. Since they do not bind water as aggressively as HA, the risk of post-injection puffiness is significantly reduced.
-
Scar Tissue and Stretch Marks: Due to their regenerative properties, they are highly effective in remodeling atrophic scars and improving the appearance of striae.
-
Protocol Priming: Many experts now use a “PN-First” strategy, administering a course of polynucleotides to improve skin health before proceeding with toxins or fillers, ensuring a more durable and natural outcome.
4. The Treatment Protocol
Unlike a single-session filler, regenerative aesthetics is a journey. A standard PN protocol typically involves:
-
Loading Phase: 3 sessions spaced 14–21 days apart.
-
Maintenance: A single “booster” session every 6 months.
This cycle ensures that the fibroblast activity remains elevated, leading to progressive improvements in skin turgor and radiance that can last well beyond the treatment period.
Conclusion: The Future is Regenerative
Polynucleotides represent the move toward a more sophisticated, biological approach to aging. By incorporating PN into your clinical portfolio, you offer your patients more than just a temporary fix; you offer them a tool for biological rejuvenation. At a time when “natural” is the most requested aesthetic outcome, Polynucleotides provide the scientific foundation to deliver it.
Scientific References & Clinical Resources
-
Cavallini, M., et al. (2021). The Use of Polynucleotides in Aesthetics: A Systematic Review. Journal of Cosmetic Dermatology.
-
Colangelo, M. T., et al. (2021). Polynucleotide-based bio-stimulants in skin rejuvenation. Aesthetic Surgery Journal.
-
Massirone, A. (2020). Polynucleotides HPT: the state of the art in regenerative aesthetics. Journal of Aesthetic Nursing.
